Literature DB >> 9699921

Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

B Alexander1, M Aslam, A Nobin, I S Benjamin.   

Abstract

Changes in brain 5-HT turnover which have been associated with portal-systemic encephalopathy (PSE) in man were studied in rats with experimental PSE for intervals up to 15 weeks following the surgical construction of end-to-side portacaval shunts (PCS). These were compared to changes measured in portacaval transposed rats (PCT) which, show little hepatic dysfunction or cerebral abnormalities but, in common with the PCS rat, sustain total portal-systemic diversion. Thus any differences between these two groups were indicative of hepatic dysfunction and not the systemic diversion of portal blood. After 15 weeks, sustained increases were measured in brainstem and cerebral concentrations of the catabolite of 5-hydroxytryptamine (5-HT), 5-hydroxyindole acetic acid (5-HIAA), from 0.25+/-0.01 to 0.68+/-0.01*** microg g(-1) brain and from 0.18+/-0.01 to 0.31+/-0.03*** microg g(-1) brain respectively in PCS rats and were statistically greater to those measured in the brainstem and cerebrum of PCT and control rats. Sustained increases in cerebral concentrations alone of 5-hydroxytryptophan (5-HTP), the precursor of 5-HT, from 0.17+/-0.01 to 0.23+/-0.02 microg g(-1) brain were measured in PCS rats and were significantly*** greater than in PCT control rats after 15 weeks. Some early increases in 5-HTP were measured in PCS above control rats but these were not significant after 15 weeks. No sustained significant differences between the 3 groups were measured in 5-HT after 15 weeks. These data confirm previous evidence that the elevations in 5-HTP and 5-HIAA concentrations observed in experimental chronic liver failure and PSE are due to liver dysfunction and not portal-systemic diversion and may contribute additional information regarding the role of derangements in central 5-HT turnover as one of the causes of PSE. ***p<0.001, Newman-Keuls ANOVAR followed by Student's unpaired t-test for individual comparisons, (data shown are mean +/- SEM).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699921     DOI: 10.1023/a:1020661230502

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

2.  Neurotransmittor changes in the rat brain after portacaval anastomosis.

Authors:  G Simert; A Mobin; E Rosengren; J Vang
Journal:  Eur Surg Res       Date:  1978       Impact factor: 1.745

3.  Hepatic blood flow studies in the rat before and after portacaval transposition.

Authors:  C J Ryan; J Guest; S Ryan; A M Harper; L H Blumgart
Journal:  Br J Exp Pathol       Date:  1978-02

4.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

Review 5.  Hepatic encephalopathy and ascites.

Authors:  R Jalan; P C Hayes
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

6.  Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.

Authors:  J L Venero; A Machado; J Cano
Journal:  J Neurochem       Date:  1991-06       Impact factor: 5.372

7.  Brain monoamine metabolism and behavior in portacaval-shunted rats.

Authors:  F Bengtsson; F H Gage; B Jeppsson; A Nobin; E Rosengren
Journal:  Exp Neurol       Date:  1985-10       Impact factor: 5.330

8.  The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology.

Authors:  F Bengtsson; M Bugge; A Brun; B Falck; K G Henriksson; A Nobin
Journal:  J Neurol Sci       Date:  1988-01       Impact factor: 3.181

9.  Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

Authors:  J Wahren; J Denis; P Desurmont; L S Eriksson; J M Escoffier; A P Gauthier; L Hagenfeldt; H Michel; P Opolon; J C Paris; M Veyrac
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

10.  Plasma GABA-like activity in rats with hepatic encephalopathy is due to GABA and taurine.

Authors:  J E Maddison; D K Leong; P R Dodd; G A Johnston
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

View more
  2 in total

1.  Hyperammonaemia reduces intracellular 22Na (sodium) ion and extracellular 86Rb ion concentrations in the blood-brain barrier of the rat.

Authors:  Barry Alexander; Kevin A Smart; Malcolm B Segal; Jane E Preston
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

2.  A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats.

Authors:  B Alexander; X Li; I S Benjamin; M B Segal; R Sherwood; J E Preston
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.